Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
07:12am, Monday, 20'th Apr 2026
– Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics – – Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Approxim
QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes
01:16pm, Saturday, 18'th Apr 2026
QuidelOrtho's (QDEL) reported weakness is concentrated in post-COVID Point of Care and the deliberate US donor-screening exit. However, the rest of their portfolio is actually growing. Labs is the pri
QuidelOrtho Stock Sinks To 52-Week Low - Here's Why
01:45pm, Thursday, 16'th Apr 2026
The diagnostic healthcare products maker reported preliminary unaudited revenue in the range of $615 million to $620 million for the first quarter, compared to the consensus of $680.59 million.
QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance
04:15pm, Wednesday, 15'th Apr 2026
SAN DIEGO, April 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, today announced preliminary unaudited revenu
QuidelOrtho Corp (QDEL) Shares Surge 7.7% -- What GF Score of 63 Tells Investors
07:20pm, Tuesday, 14'th Apr 2026
On April 14, 2026, QuidelOrtho Corp (QDEL) shares rose 7.7% to a current price of $17.32. Despite today's positive movement, QDEL's stock has experienced signif
QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co.
04:57am, Saturday, 04'th Apr 2026
JPMorgan Chase and Co. lessened its holdings in QuidelOrtho Corporation (NASDAQ: QDEL) by 85.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and
Head to Head Comparison: QuidelOrtho (NASDAQ:QDEL) vs. Quipt Home Medical (NASDAQ:QIPT)
01:10am, Wednesday, 01'st Apr 2026
Quipt Home Medical (NASDAQ: QIPT - Get Free Report) and QuidelOrtho (NASDAQ: QDEL - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two compa
QuidelOrtho (NASDAQ:QDEL) Reaches New 52-Week Low – What’s Next?
02:39am, Sunday, 29'th Mar 2026
QuidelOrtho Corporation (NASDAQ: QDEL - Get Free Report) shares reached a new 52-week low during mid-day trading on Friday. The company traded as low as $14.75 and last traded at $15.0080, with a volu
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of “Reduce” by Brokerages
02:29am, Thursday, 26'th Mar 2026
QuidelOrtho Corporation (NASDAQ: QDEL - Get Free Report) has been given an average rating of "Reduce" by the six ratings firms that are presently covering the stock, MarketBeat reports. Three equities
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
07:00am, Tuesday, 24'th Mar 2026
SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment of Na
ArrowMark Colorado Holdings LLC Sells 181,325 Shares of QuidelOrtho Corporation $QDEL
03:49am, Sunday, 15'th Mar 2026
ArrowMark Colorado Holdings LLC lessened its position in QuidelOrtho Corporation (NASDAQ: QDEL) by 18.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The institu
Why Is QuidelOrtho (QDEL) Down 24.5% Since Last Earnings Report?
12:36pm, Friday, 13'th Mar 2026
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock?
Rice Hall James Buys QuidelOrtho Stock
09:05am, Monday, 09'th Mar 2026
Rice Hall James purchased 574,877 shares of QuidelOrtho stock in the fourth quarter. The quarter-end position value grew by $16.2 million, reflecting both additional shares and price changes.
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
09:18pm, Sunday, 01'st Mar 2026
A board director at QuidelOrtho Corp. acquired 10,000 common shares on Feb. 13, 2026, at an average price of around $23.96 per share, totaling ~$240,000. All shares were acquired for direct ownership;
Faster Cardiac Answers with High‑Sensitivity Troponin
09:17am, Thursday, 19'th Feb 2026
SAN DIEGO, Feb. 19, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carl
